Welcome to LookChem.com Sign In|Join Free

CAS

  • or

33948-19-5

Post Buying Request

33948-19-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

33948-19-5 Usage

Chemical Properties

Green Solid

Uses

Carbamazepine intermediate.

Check Digit Verification of cas no

The CAS Registry Mumber 33948-19-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,9,4 and 8 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 33948-19:
(7*3)+(6*3)+(5*9)+(4*4)+(3*8)+(2*1)+(1*9)=135
135 % 10 = 5
So 33948-19-5 is a valid CAS Registry Number.
InChI:InChI=1/C15H12ClNO/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-8H,9-10H2

33948-19-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Iminodibenzylcarbonyl chloride

1.2 Other means of identification

Product number -
Other names Iminodibenzyl-5-Carbonyl Bromide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:33948-19-5 SDS

33948-19-5Synthetic route

phosgene
75-44-5

phosgene

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

Conditions
ConditionsYield
In toluene at 90 - 95℃; for 3.5h;90%
With sodium hydroxide In chlorobenzene at 100 - 115℃; for 4h;80%
With toluene
With toluene
n-butyllithium
109-72-8, 29786-93-4

n-butyllithium

6-fluoro-3-[1-(3-hydroxypropyl)-4-piperidinyl]-1,2-benzisoxazole
150332-87-9

6-fluoro-3-[1-(3-hydroxypropyl)-4-piperidinyl]-1,2-benzisoxazole

A

1-[3-((10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)carbonyloxy)propyl]-4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidine, oxalate

1-[3-((10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)carbonyloxy)propyl]-4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidine, oxalate

B

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

Conditions
ConditionsYield
In hexane
9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

Conditions
ConditionsYield
With pyridine In 1,2-dichloro-ethane at 75℃; for 3h; Inert atmosphere;
With sodium hydroxide In chlorobenzene at 100 - 115℃; for 4.5h;
In chlorobenzene at 110℃; for 5h; Temperature;
With sodium hydrogencarbonate In dichloromethane at 0 - 20℃; for 12.5h;
5,10-bis(2-nitrobenzenesulfonyl)-5,10-diaza-1,14-tetradecanediamine
951010-97-2

5,10-bis(2-nitrobenzenesulfonyl)-5,10-diaza-1,14-tetradecanediamine

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

C39H47N7O9S2

C39H47N7O9S2

Conditions
ConditionsYield
In dichloromethane at 20℃; for 19h;95%
In dichloromethane at 20℃;
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

5H-dibenz[b,f]azepine-5-carbonylchloride
33948-22-0

5H-dibenz[b,f]azepine-5-carbonylchloride

Conditions
ConditionsYield
With sodium bromate; N-benzyl-N,N,N-triethylammonium chloride; bromine; dibenzoyl peroxide In chlorobenzene at 92 - 97℃; for 8.5h; Temperature; Reagent/catalyst;90.5%
Multi-step reaction with 2 steps
1: Br2 / chlorobenzene / 1.5 h / 145 - 150 °C
2: chlorobenzene / 2 h / 150 - 155 °C
View Scheme
With bromine In chlorobenzene at 80℃; for 6h; Temperature; Inert atmosphere;
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

9,10-dihydrodibenzazepine
494-19-9

9,10-dihydrodibenzazepine

Conditions
ConditionsYield
In acetonitrile electrolysis (Et4NClO4, Hg-dropelectrode);90%
Methyl-(1-methyl-[4]piperidyl)-amin
73579-08-5

Methyl-(1-methyl-[4]piperidyl)-amin

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

N-methyl-N-(1-methylpiperodin-4-yl)-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

N-methyl-N-(1-methylpiperodin-4-yl)-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane for 2h; Heating;90%
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

10,11-Dihydrocarbamazepin
3564-73-6

10,11-Dihydrocarbamazepin

Conditions
ConditionsYield
With ammonia In methanol; water at 57 - 59℃; for 1.5h;85.35%
With ethanol; ammonia
With ethanol; ammonia
pyrrolidine
123-75-1

pyrrolidine

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)(pyrrolidin-1-yl)methanone
294194-09-5

(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)(pyrrolidin-1-yl)methanone

Conditions
ConditionsYield
With triethylamine In benzene85%
4-phenyl-1-piperazine
92-54-6

4-phenyl-1-piperazine

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

(11,12-dihydro-5H-dibenzo[b,f]azepin-5-yl)(4-phenylpiperazin-1-yl)methanone
1250430-98-8

(11,12-dihydro-5H-dibenzo[b,f]azepin-5-yl)(4-phenylpiperazin-1-yl)methanone

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane83%
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

Propargylamine
2450-71-7

Propargylamine

N-(prop-2-ynyl)-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
127025-48-3

N-(prop-2-ynyl)-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0℃; for 24h; Reflux;76%
1-phenylmethylpiperazine
2759-28-6

1-phenylmethylpiperazine

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

5-[(4-benzylpiperazin-1-yl)carbonyl]-10,11-dihydro-5H-dibenzo[b,f]azepine

5-[(4-benzylpiperazin-1-yl)carbonyl]-10,11-dihydro-5H-dibenzo[b,f]azepine

Conditions
ConditionsYield
With triethylamine In dichloromethane for 2h; Heating;75%
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

methyl 3,5-diaminobenzoate
1949-55-9

methyl 3,5-diaminobenzoate

N,N'-bis(iminodibenzyl-5-carbonyl)-3,5-diaminobenzoic methyl ester
175085-87-7

N,N'-bis(iminodibenzyl-5-carbonyl)-3,5-diaminobenzoic methyl ester

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane for 24h; Heating;72%
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

2-propynyl 3-hydroxy-9β,13α-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oate

2-propynyl 3-hydroxy-9β,13α-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oate

(6bS,8aS,11R,12bS,14aR)-4,6b,8a,11,12b,14a-hexamethyl-2-oxo-11-((prop-2-yn-1-yloxy)carbonyl)-2,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14a-tetradecahydropicen-3-yl 10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxylate

(6bS,8aS,11R,12bS,14aR)-4,6b,8a,11,12b,14a-hexamethyl-2-oxo-11-((prop-2-yn-1-yloxy)carbonyl)-2,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14a-tetradecahydropicen-3-yl 10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxylate

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 0 - 25℃; for 12h;62%
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

(2S)-2-[(10,11-dihydro-5H-dibenzo[b,f]azepin-5-ylcarbonyl)amino]-3-(1H-indol-3-yl)propionic acid methyl ester

(2S)-2-[(10,11-dihydro-5H-dibenzo[b,f]azepin-5-ylcarbonyl)amino]-3-(1H-indol-3-yl)propionic acid methyl ester

Conditions
ConditionsYield
With N-ethylmorpholine; In N,N-dimethyl-formamide at 0 - 40℃;30.3%
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

N,N',N'-trimethylenediamine
142-25-6

N,N',N'-trimethylenediamine

10,11-dihydro-dibenz[b,f]azepine-5-carboxylic acid-[(2-dimethylamino-ethyl)-methyl-amide]

10,11-dihydro-dibenz[b,f]azepine-5-carboxylic acid-[(2-dimethylamino-ethyl)-methyl-amide]

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

10-bromo-10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-20-8

10-bromo-10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

Conditions
ConditionsYield
With bromine In chlorobenzene at 145 - 150℃; for 1.5h;
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

NG-tosylargine
4353-32-6

NG-tosylargine

Nα-(10,11-dihydroo-5H-dibenz[b.f]azepine-5-carbonyl)toluenesulfonyl-L-arginine

Nα-(10,11-dihydroo-5H-dibenz[b.f]azepine-5-carbonyl)toluenesulfonyl-L-arginine

Conditions
ConditionsYield
With sodium carbonate In 1,4-dioxane
Spermine
71-44-3

Spermine

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

C25H37N5O

C25H37N5O

Conditions
ConditionsYield
In dichloromethane at 20℃;
C23H34N6O8S2
951010-96-1

C23H34N6O8S2

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

C38H45N7O9S2

C38H45N7O9S2

Conditions
ConditionsYield
In dichloromethane at 20℃;
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

carbamazepin
298-46-4

carbamazepin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: Br2 / chlorobenzene / 1.5 h / 145 - 150 °C
2: chlorobenzene / 2 h / 150 - 155 °C
3: 25percent NH4OH / methanol / 5 h / 75 - 85 °C
View Scheme
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

(S)-1-(10,11-Dihydro-5H-dibenz[b,f]azepine-5-carbonyl)-4-(benzyloxycarbonyl)piperazine-2-carboxylic acid

(S)-1-(10,11-Dihydro-5H-dibenz[b,f]azepine-5-carbonyl)-4-(benzyloxycarbonyl)piperazine-2-carboxylic acid

Conditions
ConditionsYield
284 mg (24%)
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

benzylamine
100-46-9

benzylamine

10,11-dihydro-dibenzo[b,f]azepine-5-carboxylic acid benzylamide

10,11-dihydro-dibenzo[b,f]azepine-5-carboxylic acid benzylamide

Conditions
ConditionsYield
In dichloromethane at 20℃; for 27h;
C17H22N2O3*ClH
1131679-43-0

C17H22N2O3*ClH

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

C32H33N3O4
1131680-29-9

C32H33N3O4

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran
C17H22N2O3*ClH
1131679-47-4

C17H22N2O3*ClH

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

C32H33N3O4
1131680-31-3

C32H33N3O4

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

10,11-Dihydro-dibenzo[b,f]azepine-5-carboxylic acid hydrazide
1676-31-9

10,11-Dihydro-dibenzo[b,f]azepine-5-carboxylic acid hydrazide

Conditions
ConditionsYield
With hydrazine hydrate In diethyl ether; ethanol for 0.5h; Schlenk technique; Inert atmosphere;
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

[ReBr(CO)3(H2BF)]
1417342-96-1

[ReBr(CO)3(H2BF)]

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrazine hydrate / diethyl ether; ethanol / 0.5 h / Schlenk technique; Inert atmosphere
2: toluene-4-sulfonic acid / toluene / 0.5 h / 20 °C / Schlenk technique; Inert atmosphere
3: toluene / 5 h / Schlenk technique; Inert atmosphere; Reflux
View Scheme
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

C22H19N3O2
1417342-90-5

C22H19N3O2

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrazine hydrate / diethyl ether; ethanol / 0.5 h / Schlenk technique; Inert atmosphere
2: toluene-4-sulfonic acid / toluene / 0.5 h / 20 °C / Schlenk technique; Inert atmosphere
View Scheme
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

C23H22N2O2

C23H22N2O2

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0℃; for 12h; Inert atmosphere;
10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride
33948-19-5

10,11-dihydro-dibenzo[b,f]azepine-5-carbonyl chloride

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

C33H43N3O6Si

C33H43N3O6Si

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine / dichloromethane / 12 h / 0 °C / Inert atmosphere
2: triethylamine / benzene / 72 h / 111 °C / Inert atmosphere
View Scheme

33948-19-5Relevant articles and documents

Synthesis and Biological Evaluation of Celastrol Derivatives with Improved Cytotoxic Selectivity and Antitumor Activities

Feng, Jia-Hao,He, Qi-Wei,Hou, Ji-Qin,Hu, Xiao-Long,Long, Huan,Wang, Bao-Lin,Wang, Hao,Wang, Quan,Wang, Rong,Ye, Wen-Cai,Zhang, Li-Xin,Zhang, Xiao-Qi

, p. 1954 - 1966 (2021/07/20)

Cdc37 associates kinase clients to Hsp90 and promotes the development of cancers. Celastrol, a natural friedelane triterpenoid, can disrupt the Hsp90-Cdc37 interaction to provide antitumor effects. In this study, 31 new celastrol derivatives, 2a - 2d , 3a - 3g , and 4a - 4t , were designed and synthesized, and their Hsp90-Cdc37 disruption activities and antiproliferative activities against cancer cells were evaluated. Among these compounds, 4f , with the highest tumor cell selectivity (15.4-fold), potent Hsp90-Cdc37 disruption activity (IC50= 1.9 μM), and antiproliferative activity against MDA-MB-231 cells (IC50= 0.2 μM), was selected as the lead compound. Further studies demonstrated 4f has strong antitumor activities both in vitro and in vivo through disrupting the Hsp90-Cdc37 interaction and inhibiting angiogenesis. In addition, 4f exhibited less toxicity than celastrol and showed a good pharmacokinetics profile in vivo. These findings suggest that 4f may be a promising candidate for development of new cancer therapies.

N-heterocyclic (4-phenylpiperazin-1-yl)methanones derived from phenoxazine and phenothiazine as highly potent inhibitors of tubulin polymerization

Prinz, Helge,Ridder, Ann-Kathrin,Vogel, Kirsten,B?hm, Konrad J.,Ivanov, Igor,Ghasemi, Jahan B.,Aghaee, Elham,Müller, Klaus

, p. 749 - 766 (2017/02/05)

We report here a series of 27 10-(4-phenylpiperazin-1-yl)methanones derived from tricyclic heterocycles which were screened for effects on tumor cell growth, inhibition of tubulin polymerization, and induction of cell cycle arrest. Several analogues, among them the 10-(4-(3-methoxyphenyl)piperazine-1-carbonyl)-10H-phenoxazine-3-carbonitrile (16o), showed excellent antiproliferative properties, with low nanomolar GI50 values (16o, mean GI50 of 3.3 nM) against a large number (93) of cancer cell lines. Fifteen compounds potently inhibited tubulin polymerization. Analysis of cell cycle by flow cytometry revealed that inhibition of tumor cell growth was related to an induction of G2/M phase cell cycle blockade. Western blotting and molecular docking studies suggested that these compounds bind efficiently to β-tubulin at the colchicine binding site. Our studies demonstrate the suitability of the phenoxazine and phenothiazine core and also of the phenylpiperazine moiety for the development of novel and potent tubulin polymerization inhibitors.

Piperidine derivatives

-

, (2008/06/13)

Piperidine derivatives of formula STR1 wherein A is straight or branched alkyl, alkoxy-alkyl, or alkenyl; X is O or NH; Y is O, S, NH, NCN, or N-alkyl; R 1 is 6-fluoro-1,2-benzisoxazol-3-yl, 6-fluoro-1H-indazol-3-yl, or 6-fluoro-1-methyl-1H-indazol-3-yl; R 2 is alkyl or phenyl; and R 3 is phenyl optionally substituted, or R 3 is STR2 wherein Z represents a 5- or 6-membered heterocyclic ring; or R 2 and R 3 together with the nitrogen atom form a fused heterocyclic ring system; or pharmaceutically acceptable salts thereof are useful in the treatment of indications related to the CNS-system, cardiovascular system or to gastrointestinal disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 33948-19-5